These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4760056)

  • 21. Pool size, synthesis, and turnover of sulfated and nonsulfated cholic acid and chenodeoxycholic acid in patients with cirrhosis of the liver.
    Stiehl A; Ast E; Czygan P; Fröhling W; Raedsch R; Kommerell B
    Gastroenterology; 1978 Mar; 74(3):572-7. PubMed ID: 631488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bile acid kinetics in relation to endogenous tryglyceride metabolism in various types of hyperlipoproteinemia.
    Angelin B; Einarsson K; Hellström K; Leijd B
    J Lipid Res; 1978 Nov; 19(8):1004-16. PubMed ID: 731122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bile acids and plasma high density lipoproteins: biliary lipid metabolism in fish eye disease.
    Angelin B; Carlson LA
    Eur J Clin Invest; 1986 Apr; 16(2):157-62. PubMed ID: 3089811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of deoxycholic acid feeding on the elimination of cholesterol in normolipaemic subjects.
    Einarsson K; Hellström K; Kallner M
    Clin Sci Mol Med; 1974 Nov; 47(5):425-33. PubMed ID: 4611679
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in in vivo metabolism of bile acids in rat after treatment with phenobarbital.
    Cronholm T; Einarsson K; Gustafsson JA
    Lipids; 1974 Nov; 9(11):844-9. PubMed ID: 4437315
    [No Abstract]   [Full Text] [Related]  

  • 26. Validity of using 2,4-3H-labeled bile acids to study bile acid kinetics in man.
    LaRusso NF; Hoffman NE; Hofmann AF
    J Lab Clin Med; 1974 Nov; 84(5):759-65. PubMed ID: 4283799
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of neomycin and other antibiotics on serum cholesterol levels and on 7alpha-dehydroxylation of bile acids by the fecal bacterial flora in man.
    Samuel P; Holtzman CM; Meilman E; Sekowski I
    Circ Res; 1973 Oct; 33(4):393-402. PubMed ID: 4741941
    [No Abstract]   [Full Text] [Related]  

  • 28. Biliary lipid composition during treatment with different hypolipidaemic drugs.
    Angelin B; Einarsson K; Leijd B
    Eur J Clin Invest; 1979 Jun; 9(3):185-90. PubMed ID: 113218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA; Lang PD
    Atherosclerosis; 1977 Jul; 27(3):279-87. PubMed ID: 901625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ursodeoxycholic acid administration on biliary lipid composition and bile acid kinetics in cholesterol gallstone patients.
    Roda E; Roda A; Sama C; Festi D; Mazzella G; Aldini R; Barbara L
    Dig Dis Sci; 1979 Feb; 24(2):123-8. PubMed ID: 428300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative evaluation of the conversion of 25-hydroxycholesterol to bile acids in man.
    Swell L; Schwartz CC; Gustafsson J; Danielsson H; Vlahcevic ZR
    Biochim Biophys Acta; 1981 Jan; 663(1):163-8. PubMed ID: 7011410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid treatment in humans: effects on plasma and biliary lipid metabolism with special reference to very low density lipoprotein triglyceride and bile acid kinetics.
    Angelin B; Nilsell K; Einarsson K
    Eur J Clin Invest; 1986 Apr; 16(2):169-77. PubMed ID: 3089812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catabolism of cholesterol in hypercholesterolemia and its relationship to plasma triglycerides.
    Sodhi HS; Kudchodkar BJ
    Clin Chim Acta; 1973 Jun; 46(2):161-71. PubMed ID: 4355473
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of polyunsaturated fats on lipid metabolism in patients with hypertriglyceridemia.
    Grundy SM
    J Clin Invest; 1975 Feb; 55(2):269-82. PubMed ID: 233943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
    Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
    J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation and excretion of bile salt sulfates: an important metabolic pathway in cholestasis.
    Stiehl A; Thaler MM; Admirand WH
    Horm Metab Res; 1974; Suppl 4():49-51. PubMed ID: 4417997
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis.
    Nilsell K; Angelin B; Leijd B; Einarsson K
    Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of clofibrate on cholesterol metabolism.
    Kudchodkar BJ; Sodhi HS; Horlick DL; Mason DT
    Clin Pharmacol Ther; 1977 Aug; 22(2):154-63. PubMed ID: 884917
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.